LaRosée P - Search Results

1

Differential regulation of cardiac protein kinase C isozyme expression after aortic banding in rat.

Braun MU, LaRosée P, Schön S, Borst MM, Strasser RH. Braun MU, et al. Among authors: larosee p. Cardiovasc Res. 2002 Oct;56(1):52-63. doi: 10.1016/s0008-6363(02)00511-4. Cardiovasc Res. 2002. PMID: 12237166

2

Regulation of protein kinase C isozymes in volume overload cardiac hypertrophy.

Braun MU, LaRosée P, Simonis G, Borst MM, Strasser RH. Braun MU, et al. Among authors: larosee p. Mol Cell Biochem. 2004 Jul;262(1-2):135-43. doi: 10.1023/b:mcbi.0000038229.23132.9f. Mol Cell Biochem. 2004. PMID: 15532718

3

Desensitization of the pulmonary adenylyl cyclase system: a cause of airway hyperresponsiveness in congestive heart failure?

Borst MM, Beuthien W, Schwencke C, LaRosée P, Marquetant R, Haass M, Kübler W, Strasser RH. Borst MM, et al. Among authors: larosee p. J Am Coll Cardiol. 1999 Sep;34(3):848-56. doi: 10.1016/s0735-1097(99)00251-x. J Am Coll Cardiol. 1999. PMID: 10483969 Free article.

4

Cause and management of therapy resistance.

Hochhaus A, Schenk T, Erben P, Ernst T, La Rosée P, Müller MC. Hochhaus A, et al. Best Pract Res Clin Haematol. 2009 Sep;22(3):367-79. doi: 10.1016/j.beha.2009.05.004. Best Pract Res Clin Haematol. 2009. PMID: 19959087 Review.

5

Detection and quantification of residual disease in chronic myelogenous leukemia.

Hochhaus A, Weisser A, La Rosée P, Emig M, Müller MC, Saussele S, Reiter A, Kuhn C, Berger U, Hehlmann R, Cross NC. Hochhaus A, et al. Leukemia. 2000 Jun;14(6):998-1005. doi: 10.1038/sj.leu.2401811. Leukemia. 2000. PMID: 10865964 Review.

6

Current treatment of mantle cell lymphoma: results of a national survey and consensus meeting.

Witzens-Harig M, Hess G, Atta J, Zaiss M, Lenz G, Scholz C, Repp R, Reiser M, Pott C, Pelz H, La Rosée P, Kirchner H, Kiewe P, Keller U, Buske C, Viardot A, Dreyling M. Witzens-Harig M, et al. Ann Hematol. 2012 Nov;91(11):1765-72. doi: 10.1007/s00277-012-1534-y. Epub 2012 Aug 29. Ann Hematol. 2012. PMID: 22926531 Review.

7

Dynamics of BCR-ABL mutated clones prior to hematologic or cytogenetic resistance to imatinib.

Ernst T, Erben P, Müller MC, Paschka P, Schenk T, Hoffmann J, Kreil S, La Rosée P, Hehlmann R, Hochhaus A. Ernst T, et al. Haematologica. 2008 Feb;93(2):186-92. doi: 10.3324/haematol.11993. Epub 2008 Jan 26. Haematologica. 2008. PMID: 18223278 Free article.

8

Phospho-CRKL monitoring for the assessment of BCR-ABL activity in imatinib-resistant chronic myeloid leukemia or Ph+ acute lymphoblastic leukemia patients treated with nilotinib.

La Rosée P, Holm-Eriksen S, Konig H, Härtel N, Ernst T, Debatin J, Mueller MC, Erben P, Binckebanck A, Wunderle L, Shou Y, Dugan M, Hehlmann R, Ottmann OG, Hochhaus A. La Rosée P, et al. Haematologica. 2008 May;93(5):765-9. doi: 10.3324/haematol.12186. Epub 2008 Mar 26. Haematologica. 2008. PMID: 18367481 Free article.

9

Molecular pathogenesis of tyrosine kinase resistance in chronic myeloid leukemia.

La Rosée P, Hochhaus A. La Rosée P, et al. Curr Opin Hematol. 2010 Mar;17(2):91-6. doi: 10.1097/MOH.0b013e3283366be1. Curr Opin Hematol. 2010. PMID: 20071983 Review.

10

Resistance to imatinib in chronic myelogenous leukemia: mechanisms and clinical implications.

La Rosée P, Hochhaus A. La Rosée P, et al. Curr Hematol Malig Rep. 2008 Apr;3(2):72-9. doi: 10.1007/s11899-008-0012-z. Curr Hematol Malig Rep. 2008. PMID: 20425450

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

108 results

Search Page